Chronic Antioxidant for Cystic Fibrosis
Phase-Based Progress Estimates
Effectiveness
Safety
Cystic Fibrosis
Chronic Antioxidant - DietarySupplementEligibility
Any Age
All Sexes
What conditions do you have?
Select
Eligibility
Any Age
All Sexes
What conditions do you have?
Select
Study Summary
This trial will explore if oxidative stress contributes to both artery dysfunction and exercise intolerance in CF patients.
Treatment Effectiveness
Effectiveness Progress
Other trials for Cystic Fibrosis
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: Baseline, week 4, week 8, and week 12
Hour 2
Acute Change in exercise capacity (VO2 peak)
Week 12
Chronic Change in Flow mediated dilation
Chronic Change in exercise capacity (VO2 peak)
Hour 2
Acute Change in Flow mediated dilation
Trial Safety
Safety Progress
Other trials for Cystic Fibrosis
Trial Design
2 Treatment Groups
Chronic Antioxidant Treatment
1 of 2
Acute Antioxidant Treatment
1 of 2
Experimental Treatment
13 Total Participants · 2 Treatment Groups
Primary Treatment: Chronic Antioxidant · Has Placebo Group · N/A
Chronic Antioxidant Treatment
DietarySupplement
Experimental Group · 1 Intervention: Chronic Antioxidant · Intervention Types: DietarySupplementAcute Antioxidant TreatmentExperimental Group · 2 Interventions: Acute Antioxidant, Placebo · Intervention Types: DietarySupplement, Other
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, week 4, week 8, and week 12
Who is running the clinical trial?
Augusta UniversityLead Sponsor
192 Previous Clinical Trials
74,108 Total Patients Enrolled
4 Trials studying Cystic Fibrosis
143 Patients Enrolled for Cystic Fibrosis
Ryan Harris, Ph.D.4.7122 ReviewsPrincipal Investigator - Augusta University
Medical School - University of Kansas, Kansas City, Doctor of Medicine
Augusta University, Medical College of Georgia, Residency in Otolaryngology and Head and Neck Surgery
2 Previous Clinical Trials
339 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
19 Patients Enrolled for Cystic Fibrosis
5Patient Review
He's great and very straightforward.
Eligibility Criteria
Age Any Age · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments